First, ours is the first study to demonstrate that primary epithelial cells throughout the FRT accumulate TFV-DP inside the cells and, after the initial drug inoculum is cleared, gradually release TFV, and release it in sufficient amounts and in a sustained manner to protect CD4+ T cells from HIV infection. Here, CD4 is linked to HIV infectious disease.